CRGC News Broadcast
April 3, 2019

Follow this link to a listing of SEER SINQ's that have been finalized during the months of May thru December, 2018.
Highlights of this listing include: 
  • 20180065 instructs whether Immunotherapy is ever considered palliative.
  • 20180047 confirms kidney: hybrid oncocytic tumor is not reportable.
  • 20180037 advises whether a positive Cologuard test would be used for the date of diagnosis. Spoiler Alert: it is not.
The SEER Inquiry System is available at:  click here
If you have questions or concerns regarding any of the content of this CRGC News Broadcast please contact me .   

Mignon Dryden, CTR
Director, E-Reporting
Cancer Registry of Greater California